Albireo Pharma Inc Dinheiro/Ação
Qual é o Dinheiro/Ação de Albireo Pharma Inc?
O Dinheiro/Ação de Albireo Pharma Inc é 10.75
Qual é a definição de Dinheiro/Ação?
Dinheiro por ação é o dinheiro em caixa de uma empresa dividido pelas ações da empresa em circulação.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Dinheiro/Ação de empresas na Setor Health Care em NASDAQ em comparação com Albireo Pharma Inc
O que Albireo Pharma Inc faz?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Empresas com dinheiro/ação semelhantes a Albireo Pharma Inc
- Consol Inc tem Dinheiro/Ação de 10.74
- Gati tem Dinheiro/Ação de 10.74
- AXA SA tem Dinheiro/Ação de 10.74
- AXA SA tem Dinheiro/Ação de 10.74
- AXA SA tem Dinheiro/Ação de 10.74
- AXA SA tem Dinheiro/Ação de 10.74
- Albireo Pharma Inc tem Dinheiro/Ação de 10.75
- Lindsay tem Dinheiro/Ação de 10.75
- Horizon Therapeutics Plc tem Dinheiro/Ação de 10.76
- Zendesk Inc tem Dinheiro/Ação de 10.77
- Advanced Micro Devices tem Dinheiro/Ação de 10.77
- Texas Instruments tem Dinheiro/Ação de 10.77
- T-Mobile US Inc tem Dinheiro/Ação de 10.77